111 related articles for article (PubMed ID: 2787808)
21. [Pharmacokinetics of oral alminoprofen (Minalfen) in elderly patients with rheumatoid arthritis and spondylosis deformans].
Shin K; Takasaki M; Katsunuma H; Sato K; Shibuya T; Sato S; Hirayama H
Nihon Ronen Igakkai Zasshi; 1992 Nov; 29(11):881-7. PubMed ID: 1491485
[TBL] [Abstract][Full Text] [Related]
22. The pharmacokinetics of single and multiple doses of tiaprofenic acid in elderly patients with arthritis.
Hosie J; Hosie GA
Eur J Clin Pharmacol; 1987; 32(1):93-5. PubMed ID: 3582474
[TBL] [Abstract][Full Text] [Related]
23. Profile of etodolac: pharmacokinetic evaluation in special populations.
Brater DC; Lasseter KC
Clin Rheumatol; 1989 Mar; 8 Suppl 1():25-35. PubMed ID: 2525981
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of pranoprofen gel for percutaneous administration.
Choi JS; Shin SC
Drug Dev Ind Pharm; 2007 Jan; 33(1):19-26. PubMed ID: 17192247
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
Choi Y; Han H; Shin D; Lim KS; Yu KS
Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
[TBL] [Abstract][Full Text] [Related]
26. Determination of 2-(5-benzoyl-2-thienyl) propionic acid (tiaprofenic acid) in the plasma of elderly patients with multiple diseases using high-performance liquid chromatography.
Rieck W; Platt D
J Chromatogr; 1987 Oct; 421(1):206-10. PubMed ID: 3429568
[No Abstract] [Full Text] [Related]
27. Pharmacokinetics of rofecoxib in children with sickle cell hemoglobinopathy.
Prescilla RP; Frattarelli DA; Haritos D; Aranda JV; Edwards DJ
J Pediatr Hematol Oncol; 2004 Oct; 26(10):661-4. PubMed ID: 15454838
[TBL] [Abstract][Full Text] [Related]
28. Enantiospecific disposition of pranoprofen in beagle dogs and rats.
Imai T; Nomura T; Aso M; Otagiri M
Chirality; 2003 May; 15(4):312-7. PubMed ID: 12666237
[TBL] [Abstract][Full Text] [Related]
29. [Determination of oxaprozin in human plasma with high performance liquid chromatography (HPLC) and its application].
Mao M; Wang L; Jiang X; Yang L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Jun; 30(3):646-50. PubMed ID: 23865335
[TBL] [Abstract][Full Text] [Related]
30. Chiral pharmacokinetics of zaltoprofen in rats by HPLC with solid-phase extraction.
Chu VM; Kim KT; Kim SH; Lee W; Lee KC; Nguyen VL; Hoang VL; Lee YK; Park KR; Jung SH; Kang JS
J Pharm Biomed Anal; 2012 Nov; 70():567-73. PubMed ID: 22703836
[TBL] [Abstract][Full Text] [Related]
31. Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy.
An SH; Kwon YH
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1489-1496. PubMed ID: 26553195
[TBL] [Abstract][Full Text] [Related]
32. Clinical pharmacology of dilevalol (III). A pharmacokinetic study of dilevalol in elderly subjects with essential hypertension.
Fujimura A; Sugimoto K; Kumagai Y; Nakashima H; Ebihara A
J Clin Pharmacol; 1989 Nov; 29(11):1008-12. PubMed ID: 2574727
[TBL] [Abstract][Full Text] [Related]
33. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
Prompila N; Wittayalertpanya S; Komolmit P
J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
[TBL] [Abstract][Full Text] [Related]
34. Enantiomeric composition analysis of pranoprofen in equine plasma and urine by chiral liquid chromatography-tandem mass spectrometry in selected reaction monitoring mode.
Yu J; Han KS; Lee G; Paik MJ; Kim KR
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3249-54. PubMed ID: 21036111
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of oxaprozin in women receiving conjugated estrogen.
Scavone JM; Ochs HR; Greenblatt DJ; Matlis R
Eur J Clin Pharmacol; 1988; 35(1):105-8. PubMed ID: 3220091
[TBL] [Abstract][Full Text] [Related]
36. The pharmacokinetics of sustained release tiaprofenic acid in elderly arthritic patients.
Hosie GA; Hosie J
Br J Clin Pharmacol; 1987 Jul; 24(1):93-5. PubMed ID: 3620289
[TBL] [Abstract][Full Text] [Related]
37. Plasma tenoxicam concentrations after single and multiple oral doses.
Crevoisier C; Heizmann P; Forgo I; Dubach UC
Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089
[TBL] [Abstract][Full Text] [Related]
38. Effect of chronic renal failure on oxaprozin multiple-dose pharmacokinetics.
Audet PR; Knowles JA; Troy SM; Walker BR; Morrison G
Clin Pharmacol Ther; 1988 Sep; 44(3):303-9. PubMed ID: 3416552
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of tiaprofenic acid in geriatric patients with ischemic heart disease.
Platt D; Rieck W; Hilgert D; Eicher H
Arch Gerontol Geriatr; 1989 Mar; 8(2):105-15. PubMed ID: 2735784
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and bioavailability of nimesulide in goats.
Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
